Botanical species · safety record

Pelargonium reniforme

The EFSA Compendium of Botanicals holds 8 constituent measurements for Pelargonium reniforme. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Pelargonium reniforme Curtis

8Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Coumarins2
  • Ellagitannins (hydrolysable tannins)2
  • Gallotannins2
  • Lignans1
  • P-coumaric acid1

Plant parts

  • Aerial part of plants4
  • Roots and other underground parts3
  • Live plants1

Preparations

  • Solvent extraction8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CoumarinsRoots and other underground partsSolvent extractionUnspecifiedResolve DOI
CoumarinsRoots and other underground partsSolvent extractionUHPLC-MS-MSResolve DOI
Ellagitannins (hydrolysable tannins)Aerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
Ellagitannins (hydrolysable tannins)Aerial part of plantsSolvent extractionUnspecifiedResolve DOI
GallotanninsRoots and other underground partsSolvent extractionUnspecifiedResolve DOI
GallotanninsAerial part of plantsSolvent extractionUnspecifiedResolve DOI
LignansAerial part of plantsSolvent extractionNuclear Magnetic Resonance (NMR)Resolve DOI
P-coumaric acidLive plantsSolvent extractionUnspecifiedResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Latte, KP., Kolodziej, H. Pelargoniins, new ellagitannins from Pelargonium reniforme. PHYTOCHEMISTRY, 2000, vol. 54, no. 7, p. 701-708. DOI
  2. Kolodziej, Herbert. Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo (R) . Phytomedicine, 2007, vol. 14, p. 9-17. DOI
  3. Latte, Klaus Peter., Kaloga, Maki., Schaefer, Andreas., Kolodziej, Herbert. An ellagitannin, n-butyl gallate, two aryltetralin lignans, and an unprecedented diterpene ester from Pelargonium reniforme. PHYTOCHEMISTRY, 2008, vol. 69, no. 3, p. 820-826. DOI
  4. Viljoen, Alvaro M., Zhao, Jianping., Sandasi, Maxleene., Chen, Weiyang., Khan, Ikhlas A. Phytochemical distinction between Pelargonium sidoides (Umckaloabo) and P. reniforme through H-1-NMR and UHPLC-MS metabolomic profiling . Metabolomics, 2015, vol. 11, no. 3, p. 594-602. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue